News Industry News CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction May 29, 2024
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Industry News Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset October 13, 2015